Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000947871-25-000396
Filing Date
2025-04-17
Accepted
2025-04-17 08:45:02
Documents
6
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ss4719516_6k.htm 6-K 15911
2 MATERIAL CHANGE REPORT ss4719516_ex9901.htm EX-99.1 22604
3 ARRANGEMENT AGREEMENT ss4719516_ex9902.htm EX-99.2 617910
4 VOTING SUPPORT AGREEMENT BETWEEN SNDL INC. AND HARSHIL CHOVATIYA ss4719516_ex9903.htm EX-99.3 44700
5 VOTING SUPPORT AGREEMENT BETWEEN SNDL INC. AND TANVI BHANDARI ss4719516_ex9904.htm EX-99.4 44715
6 VOTING SUPPORT AGREEMENT BETWEEN SNDL INC. AND LUCAS LEONE ss4719516_ex9905.htm EX-99.5 44545
  Complete submission text file 0000947871-25-000396.txt   791532
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 25844414
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)